NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.03
+0.21 (1.18%)
Nov 4, 2024, 4:00 PM EST - Market closed

NAMS Statistics

Total Valuation

NAMS has a market cap or net worth of $1.62 billion. The enterprise value is $1.19 billion.

Market Cap 1.62B
Enterprise Value 1.19B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

NAMS has 90.02 million shares outstanding. The number of shares has increased by 108.42% in one year.

Shares Outstanding 90.02M
Shares Change (YoY) +108.42%
Shares Change (QoQ) +7.16%
Owned by Insiders (%) 1.23%
Owned by Institutions (%) 29.74%
Float 33.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 211.39
Forward PS n/a
PB Ratio 4.19
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 160.67
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.83, with a Debt / Equity ratio of 0.00.

Current Ratio 9.83
Quick Ratio 9.63
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -54.08% and return on invested capital (ROIC) is -30.72%.

Return on Equity (ROE) -54.08%
Return on Assets (ROA) -27.15%
Return on Capital (ROIC) -30.72%
Revenue Per Employee $256,000
Profits Per Employee -$7.91M
Employee Count 29
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

In the past 12 months, NAMS has paid $27,000 in taxes.

Income Tax 27,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +74.71% in the last 52 weeks. The beta is -0.00, so NAMS's price volatility has been lower than the market average.

Beta (5Y) -0.00
52-Week Price Change +74.71%
50-Day Moving Average 17.23
200-Day Moving Average 19.36
Relative Strength Index (RSI) 49.57
Average Volume (20 Days) 239,440

Short Selling Information

Short Interest 548,709
Short Previous Month 442,964
Short % of Shares Out 1.03%
Short % of Float n/a
Short Ratio (days to cover) 2.12

Income Statement

In the last 12 months, NAMS had revenue of $7.42 million and -$229.40 million in losses. Loss per share was -$2.64.

Revenue 7.42M
Gross Profit 7.42M
Operating Income -208.69M
Pretax Income -234.58M
Net Income -229.40M
EBITDA -208.63M
EBIT -208.69M
Loss Per Share -$2.64
Full Income Statement

Balance Sheet

The company has $430.71 million in cash and $562,000 in debt, giving a net cash position of $430.15 million or $4.78 per share.

Cash & Cash Equivalents 430.71M
Total Debt 562,000
Net Cash 430.15M
Net Cash Per Share $4.78
Equity (Book Value) 387.44M
Book Value Per Share 4.30
Working Capital 400.05M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$188.63 million and capital expenditures -$606,000, giving a free cash flow of -$189.24 million.

Operating Cash Flow -188.63M
Capital Expenditures -606,000
Free Cash Flow -189.24M
FCF Per Share -$2.10
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -2,811.00%
Pretax Margin -3,089.64%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -2,284.99%

Dividends & Yields

NAMS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -108.42%
Shareholder Yield -108.42%
Earnings Yield -14.13%
FCF Yield -11.66%

Analyst Forecast

The average price target for NAMS is $33.80, which is 87.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target $33.80
Price Target Difference 87.47%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 84.68%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

NAMS has an Altman Z-Score of 11.22 and a Piotroski F-Score of 1.

Altman Z-Score 11.22
Piotroski F-Score 1